MedPath

Safety and efficacy of skin care formulation

Recruiting
Conditions
Volunteers having dull skin, pigmentary spots, crow’s feet wrinkles, uneven skin tone and visible under eye dark circles
Registration Number
CTRI/2022/01/039184
Lead Sponsor
Kama Ayurveda Pvt Ltd
Brief Summary

Objective:

PRIMARY OBJECTIVE To evaluate the in-vivo efficacy andsafety of a skin care formulation in terms of even skin tone, reduction inpigmentation (dark spot) & radiant skin on healthy male & femalesubjects.

SECONDARY OBJECTIVE To evaluate the in-vivo efficacy of askin care formulation in terms signs of ageing: minimize fine lines, smoothskin texture, reducing dark circles and improvement in hydration on healthymale & female subjects

Duration of study: 28 days study

Kinetics: T0, T+14 days and T+28 days

Population: 36 (18 Females & 18 Males) volunteers

The evaluation is performed using:

1. Subject’s Self Evaluation,

2. Dermatological Evaluation: Cosmetic Acceptability,

3. Dermatological Evaluation: Efficacy

4. Chromametry

5. Corneometry

6. CLBT (Color, Luminosity, Brightness, Transparency)

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
36
Inclusion Criteria

Having dull skin and uneven skin tone Having pigmentary spot on the face of grade 2 to grade 6 according to the Bazins atlas Having Crows feet wrinkle of grade 2 and above according to the Bazins atlas Having visible under eye dark circle.

Exclusion Criteria

Having started, changed or interrupted one hormonal treatment during the past 3 months Having started, changed or stopped her tobacco consumption in the previous 6 months Having consumed caffeine-based products, alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements Having taken a medicinal treatment which could lead to hyper pigmentation in the previous 6 months Taking oral supplements with major or minor effect on whitening of skin Having had beauty treatment e.g. skin cleansing, exfoliation, scrub, mask or having applied self tanning products in the week preceding the start of the study Having applied products with anti-wrinkle action in the 2 weeks preceding the start of the study Having applied products with a depigmenting/ whitening action in the 4 weeks preceding the start of the study Having undergone physical and/or chemical treatments of the spots in the previous 6 months Having a suntanned skin on the studied areas which could interfere with the evaluations of the study For males, having not shaved their beard 24 hours prior to the day of measurement.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
evaluate of efficacy and safety of a skin care formulation in terms of even skin tone, reduction in pigmentation (dark spot), radiant skinT0, T14 days and T28 days
Secondary Outcome Measures
NameTimeMethod
efficacy of a skin care formulation in terms signs of ageing: minimize finelines, smooth skin texture, reducing dark circles and improvement in hydration

Trial Locations

Locations (1)

Mascot Spincontrol India Pvt. Ltd.

🇮🇳

Mumbai, MAHARASHTRA, India

Mascot Spincontrol India Pvt. Ltd.
🇮🇳Mumbai, MAHARASHTRA, India
Dr Raji Patil
Principal investigator
02243349191
raji@mascotspincontrol.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.